Protara Therapeutics TARA
NASDAQ TARA
$2.70 -0.06 (-2.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Protara Therapeutics (TARA) Cash & Equivalents (2013 - 2026)

Updated

Protara Therapeutics (TARA) posted Cash & Equivalents of $17.08 million for Q2 2026, down 45.8% from $31.5 million a year earlier but up 15.9% from the prior quarter.

Analysis

Protara Therapeutics (TARA) Cash & Equivalents (2013 - 2026) Analysis & Trends

At the end of FY2025, Protara Therapeutics' Cash & Equivalents came in at $49.66 million, down 69.5% from FY2024.

  • Annual Cash & Equivalents shows a five-year compound annual growth rate of -21.7% (FY2020 to FY2025).
  • In prior years, Protara Therapeutics' Cash & Equivalents was $162.8 million in FY2024 (+311.3%), $39.59 million in FY2023 (+64.1%), $24.13 million in FY2022 (-32.5%) and $35.72 million in FY2021 (-78.8%).
  • Quarterly Cash & Equivalents has run from a low of $12.55 million in Q3 2025 to a high of $162.8 million in Q4 2024 over five years.
  • On a year-over-year basis, Cash & Equivalents has declined in each of the last five quarters, with growth averaging 12.5% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2024, with growth of 311.3%; the weakest was Q1 2026, with a decline of 83.9%.
  • According to Business Quant data, Cash & Equivalents for the three prior quarters was $14.74 million (Q1 2026), $49.66 million (Q4 2025) and $12.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Protara Therapeutics 159.53 Mn 159.53 Mn - 17.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.08 Mn
Mar 31, 2026 14.74 Mn
Dec 31, 2025 49.66 Mn
Sep 30, 2025 12.55 Mn
Jun 30, 2025 31.50 Mn
Mar 31, 2025 91.46 Mn
Dec 31, 2024 162.80 Mn
Sep 30, 2024 51.76 Mn
Jun 30, 2024 89.58 Mn
Mar 31, 2024 52.23 Mn
Dec 31, 2023 39.59 Mn
Sep 30, 2023 33.77 Mn
Jun 30, 2023 33.98 Mn
Mar 31, 2023 21.04 Mn
Dec 31, 2022 24.13 Mn
Sep 30, 2022 47.50 Mn
Jun 30, 2022 33.82 Mn
Mar 31, 2022 25.44 Mn
Dec 31, 2021 35.72 Mn
Sep 30, 2021 40.74 Mn
API Access

Protara Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TARA&period=max&api_key=YOUR_API_KEY